Tag Archives: This firm is developing a coronavirus drug based on antibodies from recovered patients

Canadian drug discovery technology company AbCellera, which analyzes and identifies antibodies for pharmaceutical companies working on a coronavirus treatment and other medicines, said on Wednesday it had raised $105 million in funds. AbCellera has been working with pharmaceutical firm Eli Lilly and Co which is developing a coronavirus drug based on antibodies from patients that have recovered from the disease. …

Read More »